Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-18-038844

Director acquired 3,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ekman Lars · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-06-19 Grant or award : show line 1 in the form +3,000 6,750 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-06-19 Grant or award : show line 2 in the form Stock Option (Right to Buy) +5,000 $80.69 2028-06-19 5,000 5,000 D
Loading xslF345X03/doc4.xml…